This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XIFAXAN 550 mg tablets and has a ceiling value of $23,984.60. The contract is a firm fixed-price Indefinite Delivery/Indefinite Quantity (IDIQ) contract with a performance period through November 27, 2024. AmerisourceBergen is a for-profit organization registered in the System for Award Management (SAM.gov) and has a strong track record of providing pharmaceutical and medical products to federal agencies, particularly within the military and veterans' healthcare systems. This contract award does not have a set-aside designation, indicating open competition. The DLA Troop Support Medical is the primary contracting agency, leveraging an existing $999,999,999 IDIQ contract with AmerisourceBergen to efficiently procure essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other supplies to support military healthcare programs globally.
Generated 2/25/25, 9:48 AM